JP2023527083A5 - - Google Patents
Info
- Publication number
- JP2023527083A5 JP2023527083A5 JP2022573287A JP2022573287A JP2023527083A5 JP 2023527083 A5 JP2023527083 A5 JP 2023527083A5 JP 2022573287 A JP2022573287 A JP 2022573287A JP 2022573287 A JP2022573287 A JP 2022573287A JP 2023527083 A5 JP2023527083 A5 JP 2023527083A5
- Authority
- JP
- Japan
- Prior art keywords
- construct
- weeks
- effective dose
- administering
- sessions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063032362P | 2020-05-29 | 2020-05-29 | |
| US63/032,362 | 2020-05-29 | ||
| US202163173155P | 2021-04-09 | 2021-04-09 | |
| US63/173,155 | 2021-04-09 | ||
| US202163175842P | 2021-04-16 | 2021-04-16 | |
| US63/175,842 | 2021-04-16 | ||
| PCT/EP2021/062728 WO2021239471A1 (en) | 2020-05-29 | 2021-05-12 | Cancer treatment strategies using arenavirus vectors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023527083A JP2023527083A (ja) | 2023-06-26 |
| JP2023527083A5 true JP2023527083A5 (enExample) | 2024-06-19 |
Family
ID=75914543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022573287A Pending JP2023527083A (ja) | 2020-05-29 | 2021-05-12 | アレナウイルスベクターを使用するがんの治療方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230346906A1 (enExample) |
| EP (1) | EP4157342A1 (enExample) |
| JP (1) | JP2023527083A (enExample) |
| KR (1) | KR20230046278A (enExample) |
| AU (1) | AU2021282287A1 (enExample) |
| BR (1) | BR112022024404A2 (enExample) |
| CA (1) | CA3184791A1 (enExample) |
| CR (1) | CR20220602A (enExample) |
| IL (1) | IL298420A (enExample) |
| MX (1) | MX2022014725A (enExample) |
| PE (1) | PE20240647A1 (enExample) |
| WO (1) | WO2021239471A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2604695T1 (sl) | 2007-12-27 | 2023-03-31 | Universitaet Zuerich Prorektorat Forschung | Replikacijsko defektni arenavirusni vektorji |
| JP6818551B2 (ja) | 2013-12-03 | 2021-01-20 | ホオキパ バイオテック ジーエムビーエイチ | Ｃｍｖワクチン |
| AU2016274655B2 (en) | 2015-06-10 | 2021-06-17 | NeoTrail Therapeutics, Inc. | HPV vaccines |
| WO2023152116A1 (en) * | 2022-02-08 | 2023-08-17 | Hookipa Biotech Gmbh | Combination therapy with arenavirus particles and immune checkpoint modulators or cytokines |
| AU2024343172A1 (en) | 2023-09-15 | 2026-03-05 | Gilead Sciences, Inc. | Arenavirus formulations, methods and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI3218504T1 (sl) | 2014-11-13 | 2020-11-30 | Universite De Geneve | Tri-segmentirani arenavirusi kot vakcinski vektorji |
| AU2016274655B2 (en) | 2015-06-10 | 2021-06-17 | NeoTrail Therapeutics, Inc. | HPV vaccines |
| DK3373959T3 (da) | 2015-11-12 | 2022-09-19 | Hookipa Biotech Gmbh | Arenaviruspartikler som cancervacciner |
| IL262963B2 (en) | 2016-05-18 | 2025-01-01 | Hookipa Biotech Gmbh | Trisegmented PICHINDE viruses as vaccine vectors |
| AU2018247958A1 (en) | 2017-04-07 | 2019-10-10 | Hookipa Biotech Gmbh | Arenavirus particles to treat solid tumors |
-
2021
- 2021-05-12 BR BR112022024404A patent/BR112022024404A2/pt unknown
- 2021-05-12 CR CR20220602A patent/CR20220602A/es unknown
- 2021-05-12 MX MX2022014725A patent/MX2022014725A/es unknown
- 2021-05-12 US US17/928,098 patent/US20230346906A1/en active Pending
- 2021-05-12 JP JP2022573287A patent/JP2023527083A/ja active Pending
- 2021-05-12 IL IL298420A patent/IL298420A/en unknown
- 2021-05-12 CA CA3184791A patent/CA3184791A1/en active Pending
- 2021-05-12 EP EP21725519.9A patent/EP4157342A1/en active Pending
- 2021-05-12 WO PCT/EP2021/062728 patent/WO2021239471A1/en not_active Ceased
- 2021-05-12 PE PE2022002786A patent/PE20240647A1/es unknown
- 2021-05-12 AU AU2021282287A patent/AU2021282287A1/en active Pending
- 2021-05-12 KR KR1020227044315A patent/KR20230046278A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023527083A5 (enExample) | ||
| JP2022160401A5 (enExample) | ||
| JP2023512519A5 (enExample) | ||
| JP2023524916A (ja) | 腫瘍溶解性ウイルスと免疫チェックポイント阻害剤の併用による腫瘍治療 | |
| JP2016128513A5 (enExample) | ||
| FR2583429A1 (fr) | Vecteur d'expression de l'interferon u dans les cellules de mammifere, procede pour sa mise en oeuvre et produit obtenu et composition pharmaceutique contenant l'interferon u | |
| CN108841796A (zh) | 重组单纯疱疹病毒及其制备方法和应用 | |
| CN111363726A (zh) | 表达干扰素的溶瘤病毒及其应用 | |
| WO2014063601A1 (zh) | 诱导肿瘤特异性免疫的疫苗及其应用 | |
| CN115624524A (zh) | Peg化白蛋白修饰的溶瘤病毒静脉递送制剂的制备及其应用 | |
| JP2023552289A5 (enExample) | ||
| JP2025188115A (ja) | 新規遺伝子組換えワクシニアウイルス及びその利用 | |
| WO2020238427A1 (zh) | 特异杀伤肿瘤细胞的溶瘤病毒系统及其应用 | |
| CN101768211A (zh) | 新城疫病毒Italien株HN蛋白和F蛋白及其在基因治疗药物中的应用 | |
| CN111939262B (zh) | 一种治疗肿瘤或癌症的药物组合物和其应用 | |
| CN119101706A (zh) | C2l基因缺失的溶瘤痘苗病毒载体的构建方法及应用 | |
| Vorona et al. | Recombinant VSVs: a promising tool for virotherapy | |
| JP2022513438A5 (enExample) | ||
| KR20040097249A (ko) | 중공 나노입자를 형성하는 단백질에 질환 치료용 세포도입 물질을 융합시킨 약제 | |
| WO2025081515A1 (zh) | 一种特异性标记异源蛋白的肿瘤新抗原疫苗体系及其应用 | |
| JP2024523329A5 (enExample) | ||
| JP2023526045A5 (enExample) | ||
| JP2024511356A5 (enExample) | ||
| JP2002544236A (ja) | 組換えパラポックスウイルスに基づくとりわけ肝の慢性ウイルス感染症ならびに炎症性、変性性および増殖性疾患ならびに癌のための器官、組織および細胞特異的免疫治療薬 | |
| CN113527509B (zh) | 含有重组蛋白和保护蛋白的复合物在治疗肺鳞癌中的应用 |